Antibody against synthetic peptide corresponding to alpha-subunit residues 128-142 of nicotinic acetylcholine receptor (AChR) : the significance in myasthenia gravis (MG)
Shibuya, N.; Kanazawa, H.; Uyemura, K.
Rinsho Shinkeigaku 28(3): 315-319
1988
ISSN/ISBN: 0009-918X PMID: 3402139 Document Number: 312920
Document emailed within 1 workday
Related Documents
Heininger, K.; Fateh-Moghadam, A.; Toyka, K.V.; Besinger, U.A.; Witthöft, J. 1980: Significance of acetylcholine receptor antibody in the diagnosis and therapy monitoring of myasthenia gravis La Ricerca in Clinica E in Laboratorio 10(1): 255-258Leng, N.; Grasso, P.; Deziel, M.R.; Reichert, L.E. 1995: A synthetic peptide corresponding to glycoprotein hormone alpha subunit residues 32-46 inhibits gonadotropin binding to receptor Peptide Research 8(5): 272-277
Sher, E.; Gotti, C.; Clementi, F. 1988: Acetylcholine nicotinic receptor: a key molecule for the pathogenesis of myasthenia gravis Annali Dell'istituto Superiore di Sanita 24(1): 103-116
Vincent, A.; Newsom-Davis, J. 1982: Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset Clinical and Experimental Immunology 49(2): 266-272
Duvoisin, R.M.; Heinemann, S.F. 1993: Transcription control elements of the rat neuronal nicotinic acetylcholine receptor subunit alpha 3 Brazilian Journal of Medical and Biological Research 26(2): 137-150
Jitpimolmard, S.; Taimkao, S.; Chotmongkol, V.; Sawanyawisuth, K.; Vincent, A.; Newsom-Davis, J. 2006: Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients Journal of the Medical Association of Thailand 89(1): 68-71
Ueno, S.; Kang, J.; Takeuchi, H.; Takahashi, M.; Tarui, S. 1980: Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis Clinical and Experimental Immunology 41(1): 13-18
Ohta, M.; Ohta, K.; Mori, F.; Itoh, N.; Nishitani, H.; Hayashi, K. 1990: Improved radioassay of anti-acetylcholine receptor antibody: application for the detection of extremely low antibody titers in sera from patients with myasthenia gravis Clinical Chemistry 36(6): 911-913
Pasutharnchat, N.; Wacharapluesadee, S.; Hemachudha, T. 2012: Clinical manifestations of acetylcholine receptor antibody positive and negative myasthenia gravis Journal of the Medical Association of Thailand 95(3): 313-319
Keesey, J.; Naeim, F.; Lindstrom, J.; Zeller, E.; Herrmann, C.; Walford, R. 1978: Correlation between acetylcholine receptor antibody titer and HLA-B8 and HLA-DRw3 antigens in myasthenia gravis Transactions of the American Neurological Association 103: 188-190
Chu, C-Jing.; Yang, Y-Chun.; Wei, J-Xue.; Zhang, L. 2011: Association of nicotinic acetylcholine receptor subunit alpha-4 polymorphisms with smoking behaviors in Chinese male smokers Chinese Medical Journal 124(11): 1634-1638
Koshida, T.; Hara, K.; Obara, G.; Sata, T. 2008: Anesthetic considerations for thymectomy in a patient having an anti-acetylcholine receptor antibody without myasthenia gravis Masui. Japanese Journal of Anesthesiology 57(8): 993-995
Matsuo, H.; Batocchi, A.P.; Hawke, S.; Nicolle, M.; Jacobson, L.; Vincent, A.; Newsom-Davis, J.; Willcox, N. 1995: Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor Journal of Immunology 155(7): 3683-3692
Yoshikawa, H.; Lambert, E.H.; Walser-Kuntz, D.R.; Yasukawa, Y.; McCormick, D.J.; Lennon, V.A. 1997: A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis Journal of Immunology 159(3): 1570-1577
Willcox, H.N.; Newsom-Davis, J.; Calder, L.R. 1984: Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis Clinical and Experimental Immunology 58(1): 97-106
Tzartos, S.J.; Sophianos, D.; Efthimiadis, A. 1985: Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera Journal of Immunology 134(4): 2343-2349
Burde, R.M. 1981: Myasthenia gravis: acetylcholine receptor antibodies and beyond Journal of Clinical Neuro-Ophthalmology 1(1): 63-66
Aharonov, A.; Tarrab-Hazdai, R.; Abramsky, O.; Silman, I.; Fuchs, S. 1975: Thymus, acetylcholine receptor and myasthenia gravis Israel Journal of Medical Sciences 11(12): 1390
Berman, P.W.; Heinemann, S.F. 1984: Antigenic modulation of junctional acetylcholine receptor is not sufficient to account for the development of myasthenia gravis in receptor immunized mice Journal of Immunology 132(2): 711-717
Appel, S.H.; Elias, S.B.; Chauvin, P. 1979: The role of acetylcholine receptor antibodies in myasthenia gravis Federation Proceedings 38(10): 2381-2385